Langhua Pharmaceutical News and Resources

Zhejiang Langhua Pharmaceutical Co., Ltd. (“Langhua Pharmaceutical”), a wholly owned subsidiary of Viva Biotech Holdings, has passed its fourth on-site Current Good Manufacturing Practices (cGMP) inspection by the U.S. Food and Drug Administration (FDA). Following the inspection, the company received an